- DE40 gains after Christmas break
- Deutsche Börse to start share buyback program on January 2, 2024
- Adler gains after Bafin audit completed
Overall market situation:
Market volatility in the last days of 2023 remain limited, nevertheless, we can see increased buying activity on the European trading floors themselves. The German DAX index is currently gaining more than 0.23%. The macro calendar scheduled for today's session is almost empty.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
European companies listed during Wednesday's trading session are mostly gaining at the moment. Source: xStation 5
The German benchmark DE40 is gaining nearly 0.08% during today's session. It is worth noting that the volume still indicates a lull in market volatility. The benchmark remains in the zone of its historical maxima. Source: xStation
News:
AstraZeneca (AZN.SE) has agreed to buy Nasdaq-listed Gracell Biotechnologies for about $1.2 billion for the clinical-stage biotech company. The deal is forecast to close in the first quarter of 2024. The company's shares are currently gaining nearly 1.3%.
German chemical giant Bayer AG (BAYN.DE) announced that it has won a lawsuit brought by a man who claimed that exposure to the herbicide Roundup caused him to develop cancer. It's worth remembering, however, that just a week ago a U.S. court ordered the company to pay nearly $857 million in damages to victims in the city of Seattle.
Deutsche Börse (DB1.DE) will begin a share buyback program on January 2, 2024. The buyback of up to 14 million shares is expected to end no later than May 3, 2024.
Adler (ADJ.DE) is currently gaining more than 13% following the outcome of a completed Bafin supervisory examination, which did not order a restatement or impose a fine, but identified accounting errors in the consolidated financial statements for 2020 and 2021 and ordered their publication.
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
